A Brazilian study published in the journal Nutrients suggests that fish oil can weaken insulin resistance and reduce glucose intolerance by modulating the body’s inflammatory response.
Nuns contribute 30 years of critical insight into dementia disorders
Catholic nuns don’t make a habit of participating in long-term studies on aging and dementia, but one notable exception has yielded critical insights into cognitive resilience, neuropathology and aging-related disorders.
Labs discover new mechanisms that cause irregular heartbeat
Medicine often takes a one-size-fits-all approach, but a disorder’s root cause can vary. Vanderbilt researchers have found that for people with long QT syndrome, a heart condition that causes an irregular heartbeat, a more tailored approach could be beneficial.
New study supports caution regarding use of steroids for patients with lupus
A new study of more than 2,900 patients provides evidence that it’s likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune disease systemic lupus erythematosus (SLE).
Ethnic minority groups prescribed higher doses of antipsychotics, UK study finds
Among people prescribed antipsychotics on the NHS for a diagnosis of severe mental illness, people from ethnic minority backgrounds and those from deprived areas in the UK are prescribed higher doses, according to an analysis led by UCL researchers.
Pilot study suggests senolytic medications may boost cognition in Alzheimer’s risk group
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), which remove old (senescent) cells from the body, suggests that intermittent treatment may hold promise for improving cognitive function in older adults at risk of Alzheimer’s disease.
How the brain builds sophisticated maps to navigate and remember the world
The brain creates internal “maps” to help us navigate and learn from our surroundings, but how these maps form remains a challenge to understand. Now, a study led by Liset M. de la Prida at the Cajal Neurosciences Center (CNC-CSIC) in Madrid, in collaboration with Imperial College London, offers a fresh perspective on how spatial and experiential information is encoded in the hippocampus, a key brain region for navigation and memory.
Screening method identifies tissue-targeting molecules for better drug delivery
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This innovation could help solve issues related to drug treatments for, for example, cancer and brain diseases, particularly as regards drug efficacy.
Previously unidentified genetic determinants of rare disease discovered
A new study involving UCL researchers has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
Obinutuzumab efficacious for renal response in lupus nephritis
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone, according to a study published online Feb. 7 in the New England Journal of Medicine. The research was published to coincide with the International Society of Nephrology annual World Congress of Nephrology, held from Feb. 6 to 9 in New Delhi.